Vicore Pharma Holding AB (publ)

Vicore Pharma Holding AB (publ)verified

VICO.ST

Price:

$10.28

Market Cap:

$2.41B

Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases. The company is developing VP01, a small molecule compound for oral administration that is in phase II clinical trial for the treatment of interstitial lung diseases, idiopathic pulmonary fibrosis (IPF), systemic sclerosis, and COVID-19; and VP02, a formulation and delivery route for an existing immunomodulatory compound, which is preclinical trials to treat patients with IPF. It has a cooperation and development agreement with Emeriti Bio AB; license agreement with Nanologica AB (publ); and a collaboration agreement with Alex Therapeutics AB for the de...[Read more]

Industry

Biotechnology

IPO Date

2015-12-10

Stock Exchange

STO

Ticker

VICO.ST

The PE Ratio as of December 2025 (TTM) for Vicore Pharma Holding AB (publ) (VICO.ST) is -5.33

According to Vicore Pharma Holding AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -5.33. This represents a change of 7.14% compared to the average of -4.97 of the last 4 quarters.

Vicore Pharma Holding AB (publ) (VICO.ST) Historical PE Ratio (quarterly & annually)

How has VICO.ST PE Ratio performed in the past?

The mean historical PE Ratio of Vicore Pharma Holding AB (publ) over the last ten years is -13.77. The current -5.33 PE Ratio has changed 3.77% with respect to the historical average. Over the past ten years (40 quarters), VICO.ST's PE Ratio was at its highest in in the March 2018 quarter at 13.67. The PE Ratio was at its lowest in in the September 2017 quarter at -60.07.

Quarterly (TTM)
Annual

Average

-13.77

Median

-11.31

Minimum

-39.56

Maximum

-3.18

Vicore Pharma Holding AB (publ) (VICO.ST) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Vicore Pharma Holding AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 163.46%

Maximum Annual PE Ratio = -3.18

Minimum Annual Increase = -437.69%

Minimum Annual PE Ratio = -39.56

Quarterly (TTM)
Annual
YearPE RatioChange
2024-11.29163.46%
2023-4.29-1.75%
2022-4.3637.06%
2021-3.18-71.89%
2020-11.3271.22%
2019-6.61-59.63%
2018-16.38-23.50%
2017-21.41-45.88%
2016-39.56104.72%
2015-19.32-437.69%

Vicore Pharma Holding AB (publ) (VICO.ST) Average PE Ratio

How has VICO.ST PE Ratio performed in the past?

The current PE Ratio of Vicore Pharma Holding AB (publ) (VICO.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-6.65

5-year avg

-6.89

10-year avg

-13.77

Vicore Pharma Holding AB (publ) (VICO.ST) PE Ratio vs. Peers

How is VICO.ST’s PE Ratio compared to its peers?

Vicore Pharma Holding AB (publ)’s PE Ratio is less than Hansa Biopharma AB (publ) (-4.42), less than Egetis Therapeutics AB (publ) (-4.99), greater than BioInvent International AB (publ) (-5.86), less than Saniona AB (publ) (12.04), greater than Diamyd Medical AB (publ) (-7.79), less than Oncopeptides AB (publ) (-4.50), less than Humana AB (publ) (9.81), less than Cantargia AB (publ) (6.75), greater than SynAct Pharma AB (-10.23), greater than Xspray Pharma AB (publ) (-5.66),

Build a custom stock screener for Vicore Pharma Holding AB (publ) (VICO.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vicore Pharma Holding AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vicore Pharma Holding AB (publ) (VICO.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vicore Pharma Holding AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Vicore Pharma Holding AB (publ)'s PE Ratio?

How is the PE Ratio calculated for Vicore Pharma Holding AB (publ) (VICO.ST)?

What is the highest PE Ratio for Vicore Pharma Holding AB (publ) (VICO.ST)?

What is the 3-year average PE Ratio for Vicore Pharma Holding AB (publ) (VICO.ST)?

What is the 5-year average PE Ratio for Vicore Pharma Holding AB (publ) (VICO.ST)?

How does the current PE Ratio for Vicore Pharma Holding AB (publ) (VICO.ST) compare to its historical average?